174 445

Cited 0 times in

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis.

DC Field Value Language
dc.contributor.author천재희-
dc.date.accessioned2017-02-24T11:38:20Z-
dc.date.available2017-02-24T11:38:20Z-
dc.date.issued2016-
dc.identifier.issn1976-2283-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/146816-
dc.description.statementOfResponsibilityopen-
dc.format.extent162~163-
dc.languageEnglish-
dc.publisherEditorial Office of Gut and Liver-
dc.relation.isPartOfGUT AND LIVER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdalimumab*-
dc.subject.MESHAntibodies, Monoclonal, Humanized/therapeutic use-
dc.subject.MESHColitis, Ulcerative/drug therapy*-
dc.subject.MESHHumans-
dc.subject.MESHRemission Induction-
dc.titleUnderstanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis.-
dc.typeArticle-
dc.publisher.locationKorea (South)-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Internal Medicine-
dc.contributor.googleauthorJae Hyun Kim-
dc.contributor.googleauthorJae Hee Cheon-
dc.identifier.doi10.5009/gnl16024-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ00954-
dc.identifier.eissn2005-1212-
dc.identifier.pmid26934881-
dc.contributor.alternativeNameCheon, Jae Hee-
dc.contributor.affiliatedAuthorCheon, Jae Hee-
dc.citation.volume10-
dc.citation.number2-
dc.citation.startPage162-
dc.citation.endPage163-
dc.identifier.bibliographicCitationGUT AND LIVER, Vol.10(2) : 162-163, 2016-
dc.date.modified2017-02-24-
dc.identifier.rimsid47558-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.